Zook

Andy Zook to Lead InterSystems North America Sales as Company Meets Growing Demand

Retrieved on: 
Tuesday, September 13, 2022

InterSystems , a creative data technology provider dedicated to helping customers solve the most critical scalability, interoperability, and speed problems, today announced Andy Zook as the new Head of North America Sales.

Key Points: 
  • InterSystems , a creative data technology provider dedicated to helping customers solve the most critical scalability, interoperability, and speed problems, today announced Andy Zook as the new Head of North America Sales.
  • Zook brings more than 20 years of global technology sales experience spanning 14 countries.
  • At InterSystems, Zook will play a crucial role in the next phase of the companys growth as it meets evolving data management needs for organizations across the globe.
  • Zook comes to InterSystems after a 20-year career at analytics software company SAS where he was most recently the SVP of the Asia-Pacific region.

Zook Cabins Named to Inc. 5000 List of Fastest-Growing Privately Held US Companies

Retrieved on: 
Thursday, September 2, 2021

ATGLEN, Pa., Sept. 2, 2021 /PRNewswire-PRWeb/ --Zook Cabins, a log cabin retailer headquartered in Atglen, PA, has been named to Inc. Magazine's 2021 Inc. 5000 list of the fastest-growing privately-owned companies in the United States.

Key Points: 
  • ATGLEN, Pa., Sept. 2, 2021 /PRNewswire-PRWeb/ --Zook Cabins, a log cabin retailer headquartered in Atglen, PA, has been named to Inc. Magazine's 2021 Inc. 5000 list of the fastest-growing privately-owned companies in the United States.
  • Founded in 2006, Zook Cabins has quickly made a name nationwide as a premier modular log cabin retailer.
  • In addition to log cabins, Zook Cabins has recently expanded into the modern cabin world.
  • With quality core values, stellar customer service, and a valued reputation, Zook Cabins has changed the way log cabins are sold.

Laidlaw Venture Partners Portfolio Company Voltron Therapeutics, Inc. Names Anthony Zook, Former CEO of AstraZeneca North America, Executive Chairman

Retrieved on: 
Thursday, January 28, 2021

Mr. Zook also serves on the Laidlaw Venture Partners (LVP), the venture capital arm ofLaidlaw & Company (UK) Ltd., Investment and Operations Committee.

Key Points: 
  • Mr. Zook also serves on the Laidlaw Venture Partners (LVP), the venture capital arm ofLaidlaw & Company (UK) Ltd., Investment and Operations Committee.
  • Mr. Zook brings to Voltron a wealth of commercialization experience in the life science industry, gained primarily through his career at AstraZeneca Plc.
  • Under Mr. Zooks leadership, AstraZeneca commercialized ten blockbuster brands, each over $1 billion in sales.
  • I am delighted to have Tony assume the newly formed role of Executive Chairman of Voltrons Board of Directors.

BioSig Technologies Inc. Appoints Tony Zook to the Board of Directors

Retrieved on: 
Wednesday, July 1, 2020

Mr. Zook brings to the Company a wealth of commercialization experience in the life science industry gained primarily through his career at AstraZeneca Plc [LON:AZN].

Key Points: 
  • Mr. Zook brings to the Company a wealth of commercialization experience in the life science industry gained primarily through his career at AstraZeneca Plc [LON:AZN].
  • Along with the CEO, CFO, and Head of R&D, Mr. Zook sat on the Portfolio Investment Board (PIB), which set and approved the overall strategy for Research and Development and allocated resources by therapeutic area.
  • Im pleased to provide my executive and operating expertise to support the Companys goals and objectives, commented Mr. Zook.
  • Andrew Ballou BioSig Technologies, Inc. Vice President, Investor Relations 54 Wilton Road, 2nd floor Westport, CT 06880 [email protected] 203-409-5444, x133

Tony Zook Joins the Board of ViralClear Pharmaceuticals, a majority-owned subsidiary of BioSig Technologies, Inc.

Retrieved on: 
Tuesday, April 21, 2020

degree from Frostburg State University and an A.A. degree in chemical engineering from Pennsylvania State University.

Key Points: 
  • degree from Frostburg State University and an A.A. degree in chemical engineering from Pennsylvania State University.
  • I look forward to lending my expertise and see this company advance in the coming months, commented Mr. Zook.
  • BioSigs subsidiary ViralClear Pharmaceuticals, Inc., is seeking to develop a novel pharmaceutical to treat COVID-19.
  • Andrew Ballou BioSig Technologies, Inc. Vice President, Investor Relations 54 Wilton Road, 2nd floor Westport, CT 06880 [email protected] 203-409-5444, x133